DR REDDYS LABORATORIES
|
DR REDDYS LABORATORIES Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
| Sales | ₹27,189 Cr | ₹23,499 Cr | ₹20,549 Cr | ₹18,447 Cr | ₹16,388 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹777 Cr | ₹1,128 Cr | ₹925 Cr | ₹552 Cr | ₹1,103 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹46 Cr | ₹43 Cr | ₹71 Cr | ₹48 Cr | ₹26 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-681 Cr | ₹71 Cr | ₹-354 Cr | ₹-791 Cr | ₹24 Cr |
| Raw Material Consumed | ₹8,889 Cr | ₹7,587 Cr | ₹7,796 Cr | ₹6,869 Cr | ₹5,531 Cr |
| Opening Raw Materials | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr | ₹1,039 Cr | ₹888 Cr |
| Purchases Raw Materials | ₹5,165 Cr | ₹4,048 Cr | ₹4,455 Cr | ₹4,472 Cr | ₹3,136 Cr |
| Closing Raw Materials | ₹1,861 Cr | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr | ₹1,039 Cr |
| Other Direct Purchases / Brought in cost | ₹4,399 Cr | ₹3,367 Cr | ₹3,484 Cr | ₹2,574 Cr | ₹2,546 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹534 Cr | ₹477 Cr | ₹391 Cr | ₹321 Cr | ₹315 Cr |
| Electricity & Power | ₹534 Cr | ₹477 Cr | ₹391 Cr | ₹321 Cr | ₹315 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹5,030 Cr | ₹4,647 Cr | ₹3,886 Cr | ₹3,630 Cr | ₹3,380 Cr |
| Salaries, Wages & Bonus | ₹4,125 Cr | ₹3,851 Cr | ₹3,215 Cr | ₹3,041 Cr | ₹2,856 Cr |
| Contributions to EPF & Pension Funds | ₹397 Cr | ₹362 Cr | ₹294 Cr | ₹260 Cr | ₹250 Cr |
| Workmen and Staff Welfare Expenses | ₹426 Cr | ₹370 Cr | ₹303 Cr | ₹255 Cr | ₹212 Cr |
| Other Employees Cost | ₹82 Cr | ₹64 Cr | ₹74 Cr | ₹74 Cr | ₹62 Cr |
| Other Manufacturing Expenses | ₹2,087 Cr | ₹1,739 Cr | ₹1,602 Cr | ₹1,574 Cr | ₹1,445 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹551 Cr | ₹492 Cr | ₹405 Cr | ₹333 Cr | ₹311 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹1,536 Cr | ₹1,247 Cr | ₹1,197 Cr | ₹1,241 Cr | ₹1,135 Cr |
| General and Administration Expenses | ₹1,848 Cr | ₹1,498 Cr | ₹1,548 Cr | ₹1,252 Cr | ₹1,195 Cr |
| Rent , Rates & Taxes | ₹187 Cr | ₹157 Cr | ₹154 Cr | ₹143 Cr | ₹127 Cr |
| Insurance | ₹105 Cr | ₹109 Cr | ₹92 Cr | ₹68 Cr | ₹49 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹855 Cr | ₹610 Cr | ₹659 Cr | ₹510 Cr | ₹422 Cr |
| Traveling and conveyance | ₹297 Cr | ₹253 Cr | ₹139 Cr | ₹100 Cr | ₹165 Cr |
| Other Administration | ₹404 Cr | ₹368 Cr | ₹505 Cr | ₹432 Cr | ₹432 Cr |
| Selling and Distribution Expenses | ₹2,248 Cr | ₹1,989 Cr | ₹1,919 Cr | ₹1,568 Cr | ₹1,408 Cr |
| Advertisement & Sales Promotion | ₹393 Cr | ₹244 Cr | ₹217 Cr | ₹164 Cr | ₹139 Cr |
| Sales Commissions & Incentives | ₹36 Cr | ₹50 Cr | ₹182 Cr | ₹45 Cr | ₹23 Cr |
| Freight and Forwarding | ₹547 Cr | ₹604 Cr | ₹541 Cr | ₹587 Cr | ₹385 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹1,272 Cr | ₹1,091 Cr | ₹980 Cr | ₹772 Cr | ₹862 Cr |
| Miscellaneous Expenses | ₹122 Cr | ₹314 Cr | ₹990 Cr | ₹754 Cr | ₹1,748 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | ₹28 Cr | ₹21 Cr | ₹7.30 Cr | ₹23 Cr | ₹19 Cr |
| Losson disposal of fixed assets(net) | - | ₹121 Cr | - | ₹4.20 Cr | ₹6.70 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹94 Cr | ₹172 Cr | ₹983 Cr | ₹727 Cr | ₹1,723 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹20,078 Cr | ₹18,321 Cr | ₹17,778 Cr | ₹15,178 Cr | ₹15,047 Cr |
| Operating Profit (Excl OI) | ₹7,933 Cr | ₹6,349 Cr | ₹3,767 Cr | ₹3,870 Cr | ₹2,470 Cr |
| Other Income | ₹894 Cr | ₹1,056 Cr | ₹485 Cr | ₹291 Cr | ₹621 Cr |
| Interest Received | ₹228 Cr | ₹118 Cr | ₹97 Cr | ₹83 Cr | ₹89 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹90 Cr | - | ₹112 Cr | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | ₹0.30 Cr | - | - |
| Foreign Exchange Gains | ₹27 Cr | ₹221 Cr | ₹183 Cr | ₹124 Cr | ₹63 Cr |
| Others | ₹549 Cr | ₹717 Cr | ₹93 Cr | ₹85 Cr | ₹469 Cr |
| Operating Profit | ₹8,827 Cr | ₹7,405 Cr | ₹4,252 Cr | ₹4,161 Cr | ₹3,091 Cr |
| Interest | ₹171 Cr | ₹143 Cr | ₹96 Cr | ₹97 Cr | ₹98 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹146 Cr | ₹121 Cr | ₹96 Cr | ₹97 Cr | ₹98 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹26 Cr | ₹22 Cr | - | - | - |
| PBDT | ₹8,656 Cr | ₹7,262 Cr | ₹4,156 Cr | ₹4,064 Cr | ₹2,993 Cr |
| Depreciation | ₹1,470 Cr | ₹1,250 Cr | ₹1,165 Cr | ₹1,229 Cr | ₹1,163 Cr |
| Profit Before Taxation & Exceptional Items | ₹7,186 Cr | ₹6,012 Cr | ₹2,991 Cr | ₹2,836 Cr | ₹1,830 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹7,201 Cr | ₹6,049 Cr | ₹3,061 Cr | ₹2,884 Cr | ₹1,886 Cr |
| Provision for Tax | ₹1,623 Cr | ₹1,541 Cr | ₹879 Cr | ₹932 Cr | ₹-140 Cr |
| Current Income Tax | ₹1,946 Cr | ₹814 Cr | ₹1,101 Cr | ₹817 Cr | ₹662 Cr |
| Deferred Tax | ₹-323 Cr | ₹727 Cr | ₹-222 Cr | ₹115 Cr | ₹-802 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹20,023 Cr | ₹16,034 Cr | ₹14,240 Cr | ₹12,835 Cr | ₹11,200 Cr |
| Appropriations | ₹25,601 Cr | ₹20,541 Cr | ₹16,422 Cr | ₹14,787 Cr | ₹13,226 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹603 Cr | ₹519 Cr | ₹388 Cr | ₹547 Cr | ₹391 Cr |
| Equity Dividend % | ₹800.00 | ₹800.00 | ₹600.00 | ₹500.00 | ₹500.00 |
| Earnings Per Share | ₹334.41 | ₹270.55 | ₹131.16 | ₹117.28 | ₹121.90 |
| Adjusted EPS | ₹66.88 | ₹54.11 | ₹26.23 | ₹23.46 | ₹24.38 |
Compare Income Statement of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹104,187.3 Cr | 0.1% | -2.8% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,044.0 Cr | 1.5% | 6.5% | -1.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,877.0 Cr | 0.8% | 0.3% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,042.0 Cr | 1% | 4.4% | 18.1% | Stock Analytics | |
| CIPLA | ₹123,060.0 Cr | -0.4% | -3.8% | 1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹93,231.8 Cr | 1% | -6.5% | -12.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.1% |
-2.8% |
1.8% |
| SENSEX | 0.5% |
1.7% |
11% |
You may also like the below Video Courses